Condition or disease | Intervention/treatment | Phase |
---|---|---|
Deep Vein Thrombosis | Other: compression ultrasound | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 700 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | Evaluation of the Predictive Value of Compression Venous Ultrasound by the Emergency Physician for Excluding the Diagnosis of Proximal Deep Vein Thrombosis (DVT) in Patients With Non-high Clinical Pretest Probability |
Estimated Study Start Date : | December 1, 2022 |
Estimated Primary Completion Date : | December 1, 2022 |
Estimated Study Completion Date : | September 8, 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: Patient with clinical suspicion of deep vein thrombosis |
Other: compression ultrasound
performing a compression ultrasound
|
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Pierrick LE BORGNE, MD | 03.88.12.86.90 | pierrick.leborgne@chru-strasbourg.fr | |
Contact: Mathieu OBERLIN, MD | 03.88.12.79.85 | mathieu.oberlin@chru-strasbourg.fr |
France | |
CHU Strasbourg | |
Strasbourg, France | |
Contact: Pierrick LE BORGNE, MD 0388128690 pierrick.leborgne@chru-strasbourg.fr | |
Contact: Mathieu OBERLIN 0388127985 mathieu.oberlin@chru-strasbourg.fr |
Tracking Information | |||||||||
---|---|---|---|---|---|---|---|---|---|
First Submitted Date ICMJE | June 1, 2021 | ||||||||
First Posted Date ICMJE | June 8, 2021 | ||||||||
Last Update Posted Date | November 24, 2021 | ||||||||
Estimated Study Start Date ICMJE | December 1, 2022 | ||||||||
Estimated Primary Completion Date | December 1, 2022 (Final data collection date for primary outcome measure) | ||||||||
Current Primary Outcome Measures ICMJE |
Negative predictive value of compression ultrasound for diagnosis of deep vein thrombosis [ Time Frame: The measurement is assessed during ED stay or in 5 days if DD is positive with no DVT in compression ultrasound ] | ||||||||
Original Primary Outcome Measures ICMJE | Same as current | ||||||||
Change History | |||||||||
Current Secondary Outcome Measures ICMJE | Not Provided | ||||||||
Original Secondary Outcome Measures ICMJE | Not Provided | ||||||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||||||
Descriptive Information | |||||||||
Brief Title ICMJE | Compression Ultrasonography in Non-high Probability of Deep Vein Thrombosis | ||||||||
Official Title ICMJE | Evaluation of the Predictive Value of Compression Venous Ultrasound by the Emergency Physician for Excluding the Diagnosis of Proximal Deep Vein Thrombosis (DVT) in Patients With Non-high Clinical Pretest Probability | ||||||||
Brief Summary | Compression ultrasound is commonly used in emergency department. Accuracy to rule out deep vein thrombosis is excellent but lower then Ddimer assessment which is actually gold standard. With progress in formation of emergency physicians (EP), quality of material used, the investigators hypothesize that compression ultrasound can rule out deep vein thrombosis in case of non high probability, as standard care and DDimer assay. | ||||||||
Detailed Description | Not Provided | ||||||||
Study Type ICMJE | Interventional | ||||||||
Study Phase ICMJE | Not Applicable | ||||||||
Study Design ICMJE | Allocation: N/A Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Diagnostic |
||||||||
Condition ICMJE | Deep Vein Thrombosis | ||||||||
Intervention ICMJE | Other: compression ultrasound
performing a compression ultrasound
|
||||||||
Study Arms ICMJE | Experimental: Patient with clinical suspicion of deep vein thrombosis
Intervention: Other: compression ultrasound
|
||||||||
Publications * | Not Provided | ||||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
Recruitment Information | |||||||||
Recruitment Status ICMJE | Not yet recruiting | ||||||||
Estimated Enrollment ICMJE |
700 | ||||||||
Original Estimated Enrollment ICMJE | Same as current | ||||||||
Estimated Study Completion Date ICMJE | September 8, 2024 | ||||||||
Estimated Primary Completion Date | December 1, 2022 (Final data collection date for primary outcome measure) | ||||||||
Eligibility Criteria ICMJE |
Inclusion Criteria:
Exclusion Criteria:
|
||||||||
Sex/Gender ICMJE |
|
||||||||
Ages ICMJE | 18 Years and older (Adult, Older Adult) | ||||||||
Accepts Healthy Volunteers ICMJE | No | ||||||||
Contacts ICMJE |
|
||||||||
Listed Location Countries ICMJE | France | ||||||||
Removed Location Countries | |||||||||
Administrative Information | |||||||||
NCT Number ICMJE | NCT04917328 | ||||||||
Other Study ID Numbers ICMJE | 8114 | ||||||||
Has Data Monitoring Committee | No | ||||||||
U.S. FDA-regulated Product |
|
||||||||
IPD Sharing Statement ICMJE | Not Provided | ||||||||
Responsible Party | University Hospital, Strasbourg, France | ||||||||
Study Sponsor ICMJE | University Hospital, Strasbourg, France | ||||||||
Collaborators ICMJE | Not Provided | ||||||||
Investigators ICMJE | Not Provided | ||||||||
PRS Account | University Hospital, Strasbourg, France | ||||||||
Verification Date | November 2021 | ||||||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |